Filter by: patients
Home > Community Treatment Reports and Side Effects > Kaletra Treatment Report
What is Kaletra?

Kaletra® is a brand name for the combination of lopinavir and ritonavir, a protease inhibitor antiretroviral used in the treatment of HIV infection in combination with other antiretroviral agents.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 107 34 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Anxious mood 2 0
Swollen glands 2 0
Headaches 1 0
Other 1 0
Pregnancy 1 0

See all 115 patients currently taking Kaletra

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 6
Moderate
 11
Mild
 8
None
 9

Commonly reported side effects, conditions, and hospitalizations associated with Kaletra

Diarrhea 17
Tiredness 7
Decreased appetite 4
Metallic taste in mouth 2
Pain in shoulders 1
Impotence 1
See all 13 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Kaletra. See all 22 dosages ►

  daily 133.3 mg-33.3 mg daily 200 mg-50 mg daily 200 mg daily 400 mg daily 2 x 200 mg-50 mg daily 4 x 133.3 mg-33.3 mg daily 800 mg daily 4 x 200 mg-50 mg daily 6 x 200 mg-50 mg daily
  8 Number of Patients: 8 9 Number of Patients: 9 3 Number of Patients: 3 9 Number of Patients: 9 2 Number of Patients: 2 6 Number of Patients: 6 11 Number of Patients: 11 7 Number of Patients: 7 39 Number of Patients: 39 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Kaletra (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 18   Side effects too severe: 46%
Doctor's advice 13   Doctor's advice: 33%
Other 7   Other: 18%
Course of treatment ended 4   Course of treatment ended: 10%
Expense 3   Expense: 8%
Did not seem to work 2   Did not seem to work: 5%
Personal research 2   Personal research: 5%
Change in health plan coverage 1   Change in health plan coverage: 3%

See all 35 patients who’ve stopped taking Kaletra

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Kaletra

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Kaletra

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Kaletra

Always
 30 88%
Usually
 4 12%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Kaletra

Very
 3 9%
Somewhat
 8 24%
A little
 8 24%
Not at all
 15 44%

Cost

Paid out of pocket

Cost of Kaletra

$200+
 3 12%
$100-199
 1 4%
$50-99
 4 16%
$25-49
 4 16%
< $25
 13 52%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.